![]() Angimmune Angimmune is a biotechnology company focused on
researching the role of immunotoxins in the treatment of T-cell related diseases, including blood and skin cancers and certain autoimmune disorders. | Immunomic Therapeutics Immunomic Therapeutics (ITI) is a biotechnology company pioneering the study of the universal intracellular targeted expression (UNITE) nucleic acid immunotherapy platform. | Crozet BioPharma Crozet BioPharma is a biotechnology company developing medical countermeasures for infectious disease and cancer. | ![]() Adastra Pharmaceuticals Adastra Pharmaceuticals (previously known as Tragara Pharmaceuticals) is an oncology company developing a clinical candidate for the treatment of brain cancers, such as glioblastoma and hepatocellular carcinoma. | ![]() Theseus Pharmaceuticals Theseus Pharmaceuticals is an MA-based biotechnology company focused on oncology by developing pan-variant kinase inhibitors. | |
Founding Date | Founding Date N/A | Founding Date 2005 | Founding Date 2017 | Founding Date 2007 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Derwood, US HQ | Locations Rockville, US HQ | Locations Devens, US HQ | Locations San Diego, US HQ Princeton, US | Locations Cambridge, US HQ |
Employees | Employees 3 | Employees 244% decrease | Employees 9 | Employees 14 | Employees 14 |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 75.4m | Total funding raised N/A | Total funding raised $ 79.9m | Total funding raised $ 122.1m |
Immunomic Therapeutics (ITI) is a biotechnology company pioneering the study of the universal intracellular targeted expression (UNITE) nucleic acid immunotherapy platform.
View companyCrozet BioPharma is a biotechnology company developing medical countermeasures for infectious disease and cancer.
View company
Adastra Pharmaceuticals (previously known as Tragara Pharmaceuticals) is an oncology company developing a clinical candidate for the treatment of brain cancers, such as glioblastoma and hepatocellular carcinoma.
View company
Theseus Pharmaceuticals is an MA-based biotechnology company focused on oncology by developing pan-variant kinase inhibitors.
View company